Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Outcomes of chronic infection with hepatitis B virus (HBV) are varied, with increased morbidity reported in the context of human immunodeficiency virus (HIV) coinfection. The factors driving different outcomes are not well understood, but there is increasing interest in an HLA class I effect. We therefore studied the influence of HLA class I on HBV in an African HIV-positive cohort. We demonstrated that virologic markers of HBV disease activity (hepatitis B e antigen status or HBV DNA level) are associated with HLA-A genotype. This finding supports the role of the CD8(+) T-cell response in HBV control, and potentially informs future therapeutic T-cell vaccine strategies.

Original publication




Journal article


J Infect Dis

Publication Date





1248 - 1252


Africa, CD8+ T cells, HBV, HBeAg (hepatitis B e antigen), HIV, HLA, coinfection, immunology, viral hepatitis, Adult, Cohort Studies, Coinfection, Female, HIV Infections, HLA Antigens, Hepatitis B, Hepatitis B e Antigens, Humans, Male, Prevalence, ROC Curve